Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Locarnini

Showing results (81-90 of 132) with videos related to

Pageof 14
Sort By:
Journal of Clinical Microbiology|October 2, 2002
Monitoring drug resistance in chronic hepatitis B virus (HBV)-infected patients during lamivudine therapy: evaluation of performance of INNO-LiPA HBV DR assayAnna S F Lok, Fabien Zoulim, Stephen Locarnini, et al.
Hepatology International|August 12, 2009
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 updateYun-Fan Liaw, Nancy Leung, Jia-Horng Kao, et al.
Gastroenterology|February 5, 2008
Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: recommendations for a standardized approachJean-Michel Pawlotsky, Geoffrey Dusheiko, Angelos Hatzakis, et al.
Journal of Viral Hepatitis|May 18, 2022
Secreted hepatitis B virus splice variants differ by HBV genotype and across phases of chronic hepatitis B infectionOlivia Maslac, Josef Wagner, Vitina Sozzi, et al.
Gastroenterology|August 2, 2003
Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerasePeter Angus, Rhys Vaughan, Shelly Xiong, et al.
AIDS (London, England)|March 22, 2006
Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapyGail V Matthews, Angeline Bartholomeusz, Stephen Locarnini, et al.
Journal of Virology|September 5, 2015
Modification of Asparagine-Linked Glycan Density for the Design of Hepatitis B Virus Virus-Like Particles with Enhanced ImmunogenicityMichiko Hyakumura, Renae Walsh, Morten Thaysen-Andersen, et al.
Hepatology (Baltimore, Md.)|August 29, 2002
Preemptive use of lamivudine reduces hepatitis B exacerbation after allogeneic hematopoietic cell transplantationGeorge K K Lau, Ming-Liang He, Daniel Y T Fong, et al.
Intervirology|November 27, 2004
Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypesHelene Norder, Anne-Marie Couroucé, Pierre Coursaget, et al.
The Journal of Infectious Diseases|October 12, 2018
Impact of Hepatitis B Virus Coinfection on Human T-Lymphotropic Virus Type 1 Clonality in an Indigenous Population of Central AustraliaJocelyn Turpin, David Yurick, Georges Khoury, et al.
Pageof 14

Showing results (81-90 of 132) with videos related to

Sort By:
Pageof 14
Journal of Clinical Microbiology|October 2, 2002
Monitoring drug resistance in chronic hepatitis B virus (HBV)-infected patients during lamivudine therapy: evaluation of performance of INNO-LiPA HBV DR assayAnna S F Lok, Fabien Zoulim, Stephen Locarnini, et al.
Hepatology International|August 12, 2009
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 updateYun-Fan Liaw, Nancy Leung, Jia-Horng Kao, et al.
Gastroenterology|February 5, 2008
Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: recommendations for a standardized approachJean-Michel Pawlotsky, Geoffrey Dusheiko, Angelos Hatzakis, et al.
Journal of Viral Hepatitis|May 18, 2022
Secreted hepatitis B virus splice variants differ by HBV genotype and across phases of chronic hepatitis B infectionOlivia Maslac, Josef Wagner, Vitina Sozzi, et al.
Gastroenterology|August 2, 2003
Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerasePeter Angus, Rhys Vaughan, Shelly Xiong, et al.
AIDS (London, England)|March 22, 2006
Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapyGail V Matthews, Angeline Bartholomeusz, Stephen Locarnini, et al.
Journal of Virology|September 5, 2015
Modification of Asparagine-Linked Glycan Density for the Design of Hepatitis B Virus Virus-Like Particles with Enhanced ImmunogenicityMichiko Hyakumura, Renae Walsh, Morten Thaysen-Andersen, et al.
Hepatology (Baltimore, Md.)|August 29, 2002
Preemptive use of lamivudine reduces hepatitis B exacerbation after allogeneic hematopoietic cell transplantationGeorge K K Lau, Ming-Liang He, Daniel Y T Fong, et al.
Intervirology|November 27, 2004
Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypesHelene Norder, Anne-Marie Couroucé, Pierre Coursaget, et al.
The Journal of Infectious Diseases|October 12, 2018
Impact of Hepatitis B Virus Coinfection on Human T-Lymphotropic Virus Type 1 Clonality in an Indigenous Population of Central AustraliaJocelyn Turpin, David Yurick, Georges Khoury, et al.
Pageof 14